Angiogenesis Inhibitors and Immunomodulation in Renal Cell Cancers: The Past, Present, and Future

SIMPLE SUMMARY: In their advanced stages, the mainstay of kidney cancer treatment is with medications such as targeted or immune therapies. Breakthroughs in scientific understanding of cancer drug development have led to substantial improvements in life expectancy. Although several combinations are...

Descripción completa

Detalles Bibliográficos
Autores principales: Kasherman, Lawrence, Siu, Derrick Ho Wai, Woodford, Rachel, Harris, Carole A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946206/
https://www.ncbi.nlm.nih.gov/pubmed/35326557
http://dx.doi.org/10.3390/cancers14061406

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946206/
https://www.ncbi.nlm.nih.gov/pubmed/35326557
http://dx.doi.org/10.3390/cancers14061406

Ejemplares similares